(Q39314424)

10 September 2017

title

CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancer (English)

1 reference

10 September 2017

1 reference

1 reference

14

1 reference

10 September 2017

C Xie

1

1 reference

10 September 2017

X H Jiang

2

1 reference

10 September 2017

J T Zhang

3

1 reference

10 September 2017

T T Sun

4

1 reference

10 September 2017

J D Dong

5

1 reference

10 September 2017

A J Sanders

6

1 reference

10 September 2017

R Y Diao

7

1 reference

10 September 2017

Y Wang

8

1 reference

10 September 2017

K L Fok

9

1 reference

10 September 2017

L L Tsang

10

1 reference

10 September 2017

M K Yu

11

1 reference

10 September 2017

X H Zhang

12

1 reference

10 September 2017

Y W Chung

13

1 reference

10 September 2017

M Y Zhao

15

1 reference

10 September 2017

J H Guo

16

1 reference

10 September 2017

Z J Xiao

17

1 reference

10 September 2017

H Y Lan

18

1 reference

10 September 2017

C F Ng

19

1 reference

10 September 2017

K M Lau

20

1 reference

10 September 2017

Z M Cai

21

1 reference

10 September 2017

W G Jiang

22

1 reference

10 September 2017

H C Chan

23

1 reference

10 September 2017

language of work or name

English

0 references

publication date

16 July 2012

1 reference

10 September 2017

1 reference

10 September 2017

volume

32

1 reference

10 September 2017

issue

18

1 reference

10 September 2017

page(s)

2282-91, 2291.e1-7

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2012.251

10 September 2017

exact match

0 references

cites work

Cystic fibrosis: molecular biology and therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.251

Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.251

New horizons in the treatment of cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.251

Risk of malignancy in first-degree relatives of patients with pancreatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.251

The Risk of Cancer among Patients with Cystic Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.251

Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations and risk for pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.251

Frequency of carriers of cystic fibrosis gene among patients with myeloid malignancy and melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.251

Cystic fibrosis transmembrane conductance regulator gene mutation and lung cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.251

Methylation profile of the promoter CpG islands of 14 "drug-resistance" genes in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.251

Methylation of multiple genes as molecular markers for diagnosis of a small, well-differentiated hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.251

Global methylation pattern of genes in androgen-sensitive and androgen-independent prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.251

Promoter hypermethylation of the CFTR gene and clinical/pathological features associated with non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.251

The plasminogen activator system and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.251

UPA and PAI-1 analysis from fixed tissues - new perspectives for a known set of predictive markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.251

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.251

The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.251

miR-193b is an epigenetically regulated putative tumor suppressor in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.251

miR-193b Regulates Mcl-1 in Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.251

Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.251

Ultrasound-microbubble-mediated gene transfer of inducible Smad7 blocks transforming growth factor-beta signaling and fibrosis in rat remnant kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.251

MUC4 expression is regulated by cystic fibrosis transmembrane conductance regulator in pancreatic adenocarcinoma cells via transcriptional and post-translational mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.251

Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.251

CFTR deltaF508 carrier status, risk of breast cancer before the age of 40 and histological grading in a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.251

Regulation of cell signalling by uPAR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.251

Selectivity of the NF-{kappa}B response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.251

The nuclear factor NF-kappaB pathway in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.251

TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.251

Cystic fibrosis transmembrane conductance regulator controls lung proteasomal degradation and nuclear factor-kappaB activity in conditions of oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.251

Activation of NF-kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.251

CFTR is a negative regulator of NFkappaB mediated innate immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.251

Prostate cancer epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.251

21 January 2018

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.251

Androgen receptor is a tumor suppressor and proliferator in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.251

Mfold web server for nucleic acid folding and hybridization prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.251

Cystic fibrosis hetero- and homozygosity is associated with inhibition of breast cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.251

The cystic fibrosis delta F508 gene mutation and cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.251

Cystic fibrosis transmembrane conductance regulator (CFTR) gene 5T allele may protect against prostate cancer: a case-control study in Chinese Han population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.251

MicroRNA-193b regulates proliferation, migration and invasion in human hepatocellular carcinoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.251

Evaluation of urokinase plasminogen activator and its receptor in different grades of human prostate cancer☆

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.251

Expression of urokinase-type plasminogen activator system in prostate cancer: correlation with clinicopathological outcomes in patients undergoing radical prostatectomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.251

31 March 2020

Identifiers

DOI

10.1038/ONC.2012.251

1 reference

Dimensions Publication ID

10 September 2017

1035775671

0 references

Fatcat ID

release_hpeqhrkreralrp4l5die5wj56q

0 references

1 reference